Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure

Simin Meng1, Yi Yu1, Shuo Yu2

  • 1Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University; State Key Laboratory of Transvascular Implantation Devices; Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.

Insights

Heart failure (HF) involves energy metabolism disruptions. This review explores cardiac metabolic remodeling and new drug therapies targeting metabolism to restore heart function.

Area of Science:

  • Cardiology
  • Metabolic Medicine
  • Biochemistry

Background:

  • The heart requires significant energy, making its metabolism crucial for function.
  • Heart failure (HF) arises from disruptions in cardiac energy metabolism.
  • Current HF treatments focus on neurohormonal and hemodynamic factors, highlighting a need for metabolic targets.

Purpose of the Study:

  • To review cardiac metabolic remodeling in both healthy and failing hearts.
  • To discuss the roles of various substrates like fatty acids, glucose, ketone bodies, and branched-chain amino acids in cardiac metabolism.
  • To explore recent pharmacological interventions for HF targeting metabolic pathways.

Main Methods:

  • Literature review of physiological and pathological cardiac metabolism.
  • Analysis of studies on substrate utilization in the heart.
  • Synthesis of findings from basic research, preclinical, and clinical studies on metabolic therapies for HF.

Main Results:

  • Cardiac metabolism significantly shifts in heart failure, altering substrate preference and efficiency.
  • Dysregulation of fatty acid, glucose, ketone body, and branched-chain amino acid metabolism is implicated in HF.
  • Pharmacological targeting of cardiac metabolism shows promise in preclinical and clinical studies.

Conclusions:

  • Cardiac metabolic remodeling is a key factor in heart failure development and progression.
  • Metabolic modulators represent a promising therapeutic avenue for heart failure.
  • Further research into metabolic interventions is warranted to improve HF treatment.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K